Matches in SemOpenAlex for { <https://semopenalex.org/work/W3153669140> ?p ?o ?g. }
- W3153669140 endingPage "449" @default.
- W3153669140 startingPage "437" @default.
- W3153669140 abstract "Migraine is a leading cause of morbidity and disability worldwide. Triptans were the first migraine-specific drug class developed and have proven efficacy in treatment of this neurological disease. They are however contraindicated in patients with cardiovascular disease and possibly others, owning to their vasoconstrictive properties. This review will focus on lasmiditan, which has been called the first 'ditan' and 'neurally acting anti-migraine agent', designed to selectively agonize the serotonin 5-HT1F receptor subtype, providing anti-migraine effects without concomitant vasoconstriction. To date, lasmiditan has proven safe and effective for the acute treatment of migraine in two Phase II and four Phase III trials. Post hoc analysis revealed that the majority of treatment-emergent adverse events were CNS-related, mild-to-moderate in severity and self-limiting. The US FDA label recommends that patients not drive or operate machinery until at least 8 h after taking each dose of lasmiditan.Lay abstract Migraine is a leading cause of pain and disability worldwide. Triptans (e.g., sumatriptan) were the first migraine-specific drug class developed and have proven to be effective treatments. Triptans are however contraindicated in patients with heart disease and possibly in some subsets of migraine, due to vasoconstriction concerns. This review will focus on lasmiditan, the first 5-HT1F receptor agonist or ‘ditan’. It does not carry vasoconstrictive concerns and is safe to use in patients who cannot take triptans. To date, lasmiditan has proven safe and effective for the acute treatment of migraine in multiple medical studies. Data from these studies indicates that the most common adverse effects from lasmiditan were dizziness, tingling and sleepiness. These symptoms were generally mild-to-moderate in severity and self-limiting. The US FDA label recommends that patients not drive or operate machinery until at least 8 h after taking each dose of lasmiditan." @default.
- W3153669140 created "2021-04-26" @default.
- W3153669140 creator A5057878020 @default.
- W3153669140 creator A5063586950 @default.
- W3153669140 creator A5077535336 @default.
- W3153669140 creator A5081455819 @default.
- W3153669140 date "2021-09-01" @default.
- W3153669140 modified "2023-10-14" @default.
- W3153669140 title "Lasmiditan for the acute treatment of migraine" @default.
- W3153669140 cites W1892375736 @default.
- W3153669140 cites W1980229633 @default.
- W3153669140 cites W1987195942 @default.
- W3153669140 cites W2003712128 @default.
- W3153669140 cites W2004100259 @default.
- W3153669140 cites W2009751644 @default.
- W3153669140 cites W2013033676 @default.
- W3153669140 cites W2037610022 @default.
- W3153669140 cites W2043377214 @default.
- W3153669140 cites W2057556593 @default.
- W3153669140 cites W2085447391 @default.
- W3153669140 cites W2094631695 @default.
- W3153669140 cites W2110117270 @default.
- W3153669140 cites W2125197474 @default.
- W3153669140 cites W2126194551 @default.
- W3153669140 cites W2155971820 @default.
- W3153669140 cites W2162942726 @default.
- W3153669140 cites W2437157720 @default.
- W3153669140 cites W2577377508 @default.
- W3153669140 cites W2586533881 @default.
- W3153669140 cites W2739573493 @default.
- W3153669140 cites W2784163112 @default.
- W3153669140 cites W2789298343 @default.
- W3153669140 cites W2791153341 @default.
- W3153669140 cites W2801085490 @default.
- W3153669140 cites W2809054111 @default.
- W3153669140 cites W2895334558 @default.
- W3153669140 cites W2901869599 @default.
- W3153669140 cites W2912654919 @default.
- W3153669140 cites W2947247420 @default.
- W3153669140 cites W2947480178 @default.
- W3153669140 cites W2949055219 @default.
- W3153669140 cites W2955741090 @default.
- W3153669140 cites W2962862085 @default.
- W3153669140 cites W2964086692 @default.
- W3153669140 cites W2968453666 @default.
- W3153669140 cites W2968488935 @default.
- W3153669140 cites W2969260382 @default.
- W3153669140 cites W2970814103 @default.
- W3153669140 cites W2970892087 @default.
- W3153669140 cites W2974314845 @default.
- W3153669140 cites W2990457166 @default.
- W3153669140 cites W2990589998 @default.
- W3153669140 cites W2990970232 @default.
- W3153669140 cites W2991144521 @default.
- W3153669140 cites W2999340757 @default.
- W3153669140 cites W3000360078 @default.
- W3153669140 cites W3001392145 @default.
- W3153669140 cites W3012655256 @default.
- W3153669140 cites W3026566790 @default.
- W3153669140 cites W3027380028 @default.
- W3153669140 cites W3032926785 @default.
- W3153669140 cites W3044447482 @default.
- W3153669140 cites W3048582409 @default.
- W3153669140 cites W3081998503 @default.
- W3153669140 cites W3089223692 @default.
- W3153669140 cites W3093717514 @default.
- W3153669140 cites W3116797659 @default.
- W3153669140 cites W3126841695 @default.
- W3153669140 cites W4237416948 @default.
- W3153669140 doi "https://doi.org/10.2217/pmt-2021-0002" @default.
- W3153669140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33840206" @default.
- W3153669140 hasPublicationYear "2021" @default.
- W3153669140 type Work @default.
- W3153669140 sameAs 3153669140 @default.
- W3153669140 citedByCount "3" @default.
- W3153669140 countsByYear W31536691402021 @default.
- W3153669140 countsByYear W31536691402023 @default.
- W3153669140 crossrefType "journal-article" @default.
- W3153669140 hasAuthorship W3153669140A5057878020 @default.
- W3153669140 hasAuthorship W3153669140A5063586950 @default.
- W3153669140 hasAuthorship W3153669140A5077535336 @default.
- W3153669140 hasAuthorship W3153669140A5081455819 @default.
- W3153669140 hasConcept C126322002 @default.
- W3153669140 hasConcept C142724271 @default.
- W3153669140 hasConcept C170493617 @default.
- W3153669140 hasConcept C177713679 @default.
- W3153669140 hasConcept C197934379 @default.
- W3153669140 hasConcept C204787440 @default.
- W3153669140 hasConcept C27081682 @default.
- W3153669140 hasConcept C2777119127 @default.
- W3153669140 hasConcept C2778176773 @default.
- W3153669140 hasConcept C2778541695 @default.
- W3153669140 hasConcept C2778871607 @default.
- W3153669140 hasConcept C2778938600 @default.
- W3153669140 hasConcept C2780035454 @default.
- W3153669140 hasConcept C3017807917 @default.
- W3153669140 hasConcept C42219234 @default.
- W3153669140 hasConcept C71924100 @default.